Induction of endogenous coenzyme Q biosynthesis by administration of peroxisomal inducers

BioFactors

Volumn 9, Issue 2-4, 1999, Pages 131-139

  Turunen, Mikael ^a   Sindelar, Pavel ^a   Dallner, Gustav ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; FARNESOL; LIPID; MEVALONIC ACID; PHOSPHOTRANSFERASE; UBIQUINONE;

AGE; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; DEPHOSPHORYLATION; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; ENZYME INDUCTION; ENZYME REGULATION; ENZYME SYNTHESIS; LIPID METABOLISM; MALE; NONHUMAN; PEROXISOME; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

ANIMALIA;

EID: 0033030733     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520090207     Document Type: Article

References (24)

1. L. Ernster and G. Daliner, Biochemical, physiological and medical aspects of ubiquinone function, Biochim. Biophys. Acta 1271 (1995), 195-204.
2. A. Kalén, E.-L. Appelkvist and G. Dallner, Age-related changes in the lipid composition of rat and human tissues, Lipids 24 (1989), 579-584.
3. P.G. Elmberger, A. Kalén, E.-L. Appelkvist and G. Dallner, In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat, Eur. J. Biochem. 168 (1987), 1-11.
4. L. Ernster, Lipid peroxidation in biological membranes: mechanisms and implications, in: Active Oxygens, Lipid Peroxides, and Antioxidants, K. Yagi, ed., CRC Press, Boca Raton, 1993, pp. 1-38.
5. Y. Zhang, F. Åberg, E.-L. Appelkvist, G. Dallner and L. Ernster, Uptake of dietary coenzyme Q supplement is limited in rats, J. Nutr. 125 (1995), 446-453.
6. A. Kalén, E.-L. Appelkvist, T. Chojnacki and G. Dallner, Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis in the endoplasmatic reticulum-Golgi system of rat liver, J. Biol. Chem. 265 (1990), 1158-1164.
7. Y. Zhang, M. Turunen and E.-L. Appelkvist, Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of α-tocopherol into rat organs and cells, J. Nutr. 126 (1996), 2089-2097.
8. J. Kvannes and T. Flatmark, A flurometric assay of acyl-CoA oxidase activity by a coupled peroxidatic reaction: elimination of interfering side reactions, J. Biochem. Biophys. Meth. 23 (1991), 135-149.
9. M. Bradford, A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. (1976), 248-254.
10. F. Åberg, E.-L. Appelkvist, G. Dallner and L. Ernster, Distribution and redox state of ubiquinones in rat and human tissues, Arch. Biochem. Biophys. 295 (1992), 230-234.
11. P. Löw, E. Peterson, C. Edlund, U. Brunk and E.-L. Appelkvist, Nonmembrane associated dolichol in rat liver, Lipids 27 (1992), 1-9.
12. P. Bentley, C. Elcombe, P. Grasso, D. Stringer and H. Wiegand, Hepatic peroxisome proliferation in rodents and its significance for humans, Fd. Chem. Toxicol. 31 (1993), 857-907.
13. F. Åberg, Y. Zhang, E.-L. Appelkvist and G. Dallner, Effects of clofibrate, phthalates and probucol on ubiquinone levels, Chem.-Biol. Interact. 91 (1994), 1-14.
14. S.A. Mortensen, Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone), Clin. Investig. 71 (1993), 116-123.
15. F. Åberg, Y. Zhang, H. Teclebrhan, E.-L. Appelkvist and G. Dallner, Increases in tissue levels of ubiquinone in association with peroxisome proliferation, Chem.-Biol. Interact. 99 (1996), 205-218.
16. H. van den Bosch, R.B.H. Schutgens, R.J.A. Wanders and J.M. Tager, Biochemistry of peroxisomes, Ann. Rev. Biochem. 61 (1992), 157-197.
17. M. Turunen and G. Dallner, Elevation of ubiquinone content by peroxisomal inducers in rat liver during aging, Chem.-Biol. Interact. 116 (1998), 79-91.
18. D.C. Crick, D.A. Andres and C.J. Waechter, Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation, Biochem. Biophys. Res. Commun. 237 (1997), 483-487.
19. C.C. Corell, L. Ng and P.A. Edwards, Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, J. Biol. Chem. 269 (1994), 17 390-17 393.
20. B.M. Forman, E. Goode, J. Chen, A.E. Oro, D.J. Bradley, T. Perlmann, D.J. Noonan, L.T. Burka, T. McMorris, W.W. Lamph, R.M. Evans and C. Weinberger, Identification of a nuclear receptor that is activated by farnesol metabolites, Cell 81 (1995), 687-693.
21. J. Christophe and G. Popjak, Studies on the biosynthesis of cholesterol: XIV. The origin of prenoic acids from allyl pyrophosphates in liver enzyme systems, J. Lipid Res. 2 (1961), 244-257.
22. M. Bentinger, J. Grünler, E. Peterson, E. Swiezewska and G. Dallner, Phosphorylation of farnesol in rat liver microsomes: properties of farnesol kinase and farnesyl phosphate kinase, Arch. Biochem. Biophys. 353 (1998), 191-198.
23. F.J. Gonzales, Recent update on the PPARα-null mouse, Biochemie 79 (1997), 139-144.
24. C. Weinberger, A model for farnesoid feedback control in the mevalonate pathway, Trends Endocrinol. Metab. 7 (1996), 1-6.